ZANNETTI, BEATRICE ANNA
 Distribuzione geografica
Continente #
NA - Nord America 1.891
AS - Asia 1.579
EU - Europa 1.179
AF - Africa 118
SA - Sud America 81
OC - Oceania 4
Totale 4.852
Nazione #
US - Stati Uniti d'America 1.858
CN - Cina 444
SG - Singapore 416
VN - Vietnam 396
GB - Regno Unito 244
IT - Italia 233
SE - Svezia 158
DE - Germania 146
HK - Hong Kong 79
FR - Francia 78
IN - India 68
BR - Brasile 59
RU - Federazione Russa 55
NL - Olanda 53
CI - Costa d'Avorio 45
IE - Irlanda 42
KR - Corea 41
FI - Finlandia 40
UA - Ucraina 35
ZA - Sudafrica 30
JP - Giappone 29
BD - Bangladesh 25
TG - Togo 23
CA - Canada 21
BE - Belgio 19
EE - Estonia 18
BG - Bulgaria 17
PH - Filippine 15
TH - Thailandia 11
AR - Argentina 10
JO - Giordania 10
ES - Italia 9
MX - Messico 9
SC - Seychelles 9
ID - Indonesia 8
CH - Svizzera 6
NG - Nigeria 6
PL - Polonia 6
TW - Taiwan 6
IQ - Iraq 5
AU - Australia 4
EC - Ecuador 4
IR - Iran 4
LT - Lituania 4
TR - Turchia 4
AT - Austria 3
LB - Libano 3
PT - Portogallo 3
PY - Paraguay 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CO - Colombia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
HU - Ungheria 2
IL - Israele 2
KE - Kenya 2
RO - Romania 2
CL - Cile 1
EG - Egitto 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
KZ - Kazakistan 1
LV - Lettonia 1
MT - Malta 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PK - Pakistan 1
PS - Palestinian Territory 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VE - Venezuela 1
Totale 4.852
Città #
Singapore 291
Ashburn 239
Southend 207
Chandler 176
Fairfield 170
Hefei 96
Ann Arbor 94
Woodbridge 92
Ho Chi Minh City 89
Wilmington 82
Seattle 79
San Jose 78
Hong Kong 75
Houston 66
Hanoi 58
Beijing 57
Cambridge 53
Princeton 46
Abidjan 45
Bologna 45
New York 43
Dublin 42
Santa Clara 40
Seoul 40
Los Angeles 37
Boardman 36
Helsinki 36
Dong Ket 34
Lauterbourg 23
Lomé 23
Westminster 21
Tokyo 20
Jinan 19
Padova 19
Brussels 18
Bremen 17
Council Bluffs 17
Nanjing 16
Sofia 16
Berlin 14
Da Nang 14
Frankfurt am Main 14
Jacksonville 14
Milan 14
Turin 14
Florence 13
Rome 13
Changsha 12
Guangzhou 12
Redondo Beach 12
São Paulo 12
Redwood City 11
Saint Petersburg 11
Amman 10
Chicago 10
Haiphong 10
Munich 10
Genoa 9
Paris 9
San Diego 9
Shenyang 9
Toronto 9
Zhengzhou 9
Bengaluru 8
Dallas 8
Hyderabad 8
Nanchang 8
Buffalo 7
Jiaxing 7
Phoenix 7
Abeokuta 6
Can Tho 6
Dearborn 6
Jakarta 6
London 6
Orem 6
Shanghai 6
Washington 6
Dresden 5
Falls Church 5
Hebei 5
Montreal 5
Tianjin 5
Atlanta 4
Bangkok 4
Bern 4
Bexley 4
Bắc Giang 4
Charlotte 4
Chengdu 4
Forlì 4
Hangzhou 4
Hải Dương 4
Medford 4
Monmouth Junction 4
Mülheim 4
Naples 4
Nuremberg 4
Ottawa 4
Piscataway 4
Totale 3.123
Nome #
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease 349
Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment 270
Peripheral neuropathy induced by subcutaneous bortezomib-based induction therapy for newly diagnosed multiple myeloma. 249
Positron emission tomography with computed tomography-based diagnosis of massive extramedullary progression in a patient with high-risk multiple myeloma. 247
Bortezomib and dexamethasone as salvage therapy in patients with relapsed/refractory multiple myeloma: analysis of long-term clinical outcomes 236
Current and emerging triplet combination therapies for relapsed and refractory multiple myeloma 211
Safety and efficacy of daratumumab in dialysis-dependent renal failure secondary to multiple myeloma 210
HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment 203
Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma 202
Prognostic impact of serial measurements of serum-free light chain assay throughout the course of newly diagnosed multiple myeloma treated with bortezomib-based regimens 199
Opposite activation of the Hedgehog pathway in CD138+ plasma cells and CD138-CD19+ B cells identifies two subgroups of patients with multiple myeloma and different prognosis 198
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 179
Very Poor Outcome and Chemoresistance of Acute Myeloid Leukemia Patients with TP53 Mutations: Correlation with Complex Karyotype and Clinical Outcome 178
PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma 177
TP53 mutations are mutually exclusive with FLT3 and NPM mutations in AML patients and are strongly associated with complex karyotype and poor outcome 177
Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myeloma. 175
Role of serum free light chain assay in the detection of early relapse and prediction of prognosis after relapse in multiple myeloma patients treated upfront with novel agents 175
Multiple Myeloma: The Role of Autologous Stem Cell Transplantation in the Era of Immunotherapy 158
Long-term follow-up after autologous stem cell transplantation for light- and heavy-chain deposition disease. 158
Gene expression analysis of newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted p5 155
Novel insights and therapeutic approaches in secondary AML 146
SIRT Regulates the Molecular Interaction Between c-MYC and HIF-1α in Multiple Myeloma 145
Multiple myeloma, venous thromboembolism, and treatment-related risk of thrombosis. 135
Low WT1 Expression Identifies a Subset of Acute Myeloid Leukemia with a Distinct Genotype 127
New Horizons in Immunology and Immunotherapy of Acute Leukemias and Related Disorders 126
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 94
Overview on novel strategies and current guidelines for hematopoietic stem cell mobilisation and collection 65
Totale 4.944
Categoria #
all - tutte 13.102
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.102


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202199 0 0 0 0 0 0 0 0 0 0 0 99
2021/2022520 67 25 26 47 47 19 6 34 13 53 86 97
2022/2023611 54 97 26 97 41 57 11 37 108 15 47 21
2023/2024199 15 23 12 25 16 63 13 9 1 8 6 8
2024/2025651 32 91 54 43 79 28 55 20 7 82 42 118
2025/20261.702 173 150 127 151 180 90 146 44 392 128 77 44
Totale 4.944